Diabetes patients with high deductible health plans experience delays in seeking care

Research from the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute finds that a population of people with diabetes who were switched to high-deductible health plans had associated delays in care for dangerous blood vessel diseases. The study, “High-deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes,” appears in the […]

Read more

Adenovirus outbreak in New Jersey kills 11, officials order center to separate patients

Virus kills 11th ‘medically fragile’ child at NJ facility Adenovirus outbreak claims its 10th victim at a pediatric care center in Wanaque, New Jersey. Wanaque Center for Nursing and Rehabilitation has stopped admitting new patients until the outbreak is over; Lauren Green reports. A viral outbreak at a New Jersey pediatric facility has killed another child, health officials confirmed Friday, […]

Read more

Researchers identify factors behind inflammation in immunodeficiency patients

Oregon State University researchers have discovered two key factors behind the intestinal inflammation that plagues people suffering from a disorder that affects their immune system. The findings, published in Clinical Immunology, are important because common variable immunodeficiency, known as CVID, afflicts hundreds of thousands of people worldwide. A significant proportion of them will have potentially life-threatening intestinal problems that include […]

Read more

Small populations of normal cells affect immunity in patients with XLP1

Human SH2D1A mutations resulting in X-linked lymphoproliferative syndrome type 1 (XLP1) are associated with a unique susceptibility to the Epstein-Barr virus (EBV), which may lead to fatal infectious mononucleosis (FIM). Many studies have attempted to elucidate an appropriate treatment for XLP1 that does not involve hematopoietic stem cell transplantation (HSCT); clinical evidence supporting such treatments has been minimal, until now. […]

Read more

Why Baby Boomers Should Get Tested for Hepatitis C

Getting tested is important because when left untreated hepatitis C can become chronic in adults who contract it.(Getty Images) If you’re one of the 74 million baby boomers in the United States – people born between 1946 and 1964 – you probably think about a host of health issues. The ABCs (D's and E's) of Hepatitis Chances are you pay […]

Read more

Study shows immunotherapy drug helps patients with metastatic melanoma

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients. The study is one of the first clinical trials aimed at treating the brain metastases with this […]

Read more

PTSD Patients Do Best When They Choose Their Treatment

TUESDAY, Nov. 6, 2018 — When people with post-traumatic stress disorder (PTSD) choose their own treatment — be it medication or counseling — they respond better, a new study finds. The study included 200 adult patients, including military veterans and survivors of sexual assault, seen at outpatient clinics in Seattle and Cleveland. They were asked if they preferred treatment with […]

Read more

How Can I Find the Best Psychiatrist?

According to the National Institute of Mental Health, nearly 1 in 5 U.S. adults lives with a mental illness.(Getty Images) The brain is an intricate organ, and with that complexity comes the possibility for things to go wrong. Although neurologists take care of certain aspects of the brain and diseases that begin there, there’s more to having a healthy brain […]

Read more

Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients

NEW YORK & INDIANAPOLIS–(BUSINESS WIRE October 23, 2018 )–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients with osteoarthritis (OA) pain treated for 16 weeks. The study met all three co-primary efficacy endpoints, demonstrating […]

Read more